Shoshu Mitsuyama Selected Research

Shoshu Mitsuyama Research Topics

Disease

34	Breast Neoplasms (Breast Cancer) 08/2020 - 01/2002
8	Neoplasms (Cancer) 09/2023 - 01/2002
6	Neoplasm Metastasis (Metastasis) 11/2018 - 01/2002
3	Neutropenia 01/2010 - 05/2004
3	Leukopenia 03/2007 - 05/2004
2	Dyspnea (Shortness of Breath) 04/2010 - 12/2004
2	Liver Diseases (Liver Disease) 01/2010 - 09/2008
2	Hypersensitivity (Allergy) 09/2008 - 10/2006
2	Lymphatic Metastasis 08/2008 - 08/2005
2	Stomach Neoplasms (Stomach Cancer) 04/2006 - 12/2004
1	Hemangiosarcoma (Angiosarcoma) 11/2023
1	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2018
1	Ductal Carcinoma 11/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2018
1	Inflammatory Breast Neoplasms 07/2012
1	Febrile Neutropenia 07/2012
1	Long Term Adverse Effects 08/2011
1	Bone Fractures (Bone Fracture) 06/2010
1	Disease Progression 04/2010
1	Cardiotoxicity 04/2010
1	Sigmoid Neoplasms 07/2008
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2006
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 08/2005
1	Nausea 07/2005
1	Alopecia (Baldness) 07/2005
1	Anorexia 07/2005
1	Constipation 07/2005
1	Fatigue 07/2005
1	Vomiting 07/2005
1	Cicatrix (Scar) 12/2004
1	Intraductal Papilloma 03/2003
1	Carcinoma (Carcinomatosis) 03/2003

Drug/Important Bio-Agent (IBA)

9	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 12/2004
8	Docetaxel (Taxotere)FDA Link 08/2012 - 05/2004
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015 - 08/2005
6	AnthracyclinesIBA 04/2017 - 05/2004
6	Epirubicin (Ellence)FDA LinkGeneric 01/2015 - 01/2008
5	Estrogen ReceptorsIBA 01/2018 - 05/2004
5	Taxoids (Taxanes)IBA 04/2017 - 06/2005
5	Capecitabine (Xeloda)FDA Link 01/2017 - 05/2004
3	Hormones (Hormone)IBA 01/2018 - 06/2010
3	Trastuzumab (Herceptin)FDA Link 01/2017 - 10/2012
3	Fluorouracil (Carac)FDA LinkGeneric 01/2015 - 03/2003
3	Anastrozole (Arimidex)FDA LinkGeneric 03/2012 - 06/2010
2	Toremifene (Fareston)FDA Link 01/2018 - 08/2011
2	LipidsIBA 01/2018 - 08/2011
2	human ERBB2 proteinIBA 01/2017 - 01/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2012 - 05/2005
2	Tamoxifen FDA LinkGeneric 03/2012 - 06/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2006 - 08/2005
2	Vinorelbine (Navelbine)FDA LinkGeneric 07/2005 - 06/2005
2	Proteins (Proteins, Gene)FDA Link 07/2005 - 03/2003
1	Anaplastic Lymphoma KinaseIBA 09/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2020
1	Letrozole (Femara)FDA LinkGeneric 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	eribulin FDA Link 04/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Lapatinib (GW572016)FDA Link 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2015
1	Epidermal Growth Factor (EGF)IBA 10/2012
1	taxaneIBA 08/2010
1	titanium silicide (TS-1)IBA 08/2010
1	Aromatase InhibitorsIBA 06/2010
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2010
1	Alanine Transaminase (SGPT)IBA 01/2010
1	Coloring Agents (Dyes)IBA 05/2006
1	AlkaloidsIBA 07/2005
1	Antineoplastic Agents (Antineoplastics)IBA 05/2005
1	Oxygen (Dioxygen)IBA 12/2004
1	doxifluridineIBA 05/2004
1	thiamine triphosphorate (TTP)IBA 05/2004
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 03/2003
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2003
1	EnzymesIBA 03/2003
1	CarbohydratesIBA 01/2002
1	Carcinoembryonic AntigenIBA 01/2002
1	AntigensIBA 01/2002
1	Tumor Biomarkers (Tumor Markers)IBA 01/2002
1	Peptides (Polypeptides)IBA 01/2002

Therapy/Procedure

18	Therapeutics 11/2023 - 05/2004
8	Drug Therapy (Chemotherapy) 08/2012 - 03/2003
3	Mastectomy (Mammectomy) 11/2018 - 08/2005
3	Neoadjuvant Therapy 07/2018 - 08/2012
2	Radiotherapy 11/2023 - 01/2006
2	Combination Drug Therapy (Combination Chemotherapy) 04/2010 - 05/2004
2	Gastrectomy 04/2006 - 12/2004
1	Radiofrequency Ablation 01/2018
1	Segmental Mastectomy (Lumpectomy) 08/2013
1	ET protocol 08/2012
1	Choledochostomy 08/2008
1	Ileostomy 07/2008
1	Treatment Delay 03/2007
1	Injections 05/2006
1	Gastroenterostomy 04/2006
1	Drug Tapering 05/2004